Mogamulizumab-kpkc Intravenous and Prolixin Oral Concentrate
Determining the interaction of Mogamulizumab-kpkc Intravenous and Prolixin Oral Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: fluphenazine
Brand name: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate
Synonyms: Prolixin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Proloprim
- Mogamulizumab-kpkc Intravenous-Promacot
- Mogamulizumab-kpkc Intravenous-Promacot Injection, Intravenous
- Mogamulizumab-kpkc Intravenous-Promacta
- Mogamulizumab-kpkc Intravenous-Promacta (Eltrombopag Powder for Suspension)
- Mogamulizumab-kpkc Intravenous-Promacta (Eltrombopag Tablets)
- Prolixin Oral Concentrate-Molindone
- Prolixin Oral Concentrate-Mometasone (Oral Inhalation)
- Prolixin Oral Concentrate-Mometasone and Formoterol
- Prolixin Oral Concentrate-Mometasone and formoterol Inhalation
- Prolixin Oral Concentrate-Mometasone Cream
- Prolixin Oral Concentrate-Mometasone Furoate